Cisplatin Induced Emesis: Preliminary Results Indicative of Changes in Plasma Levels of 5-hydroxytryptamine

Overview

Journal Br J Cancer

Specialty Oncology

Date 1990 Nov 1

PMID 2173945

Citations 13

Authors

N M Barnes

J Ge

W G Jones

R J Naylor

J A Rudd

Affiliations

Soon will be listed here.

Citing Articles

Effect and Mechanism of Herbal Medicines on Cisplatin-Induced Anorexia.

Min D, Kim B, Ko S, Kim W Pharmaceuticals (Basel). 2022; 15(2).

PMID: 35215322 PMC: 8877473. DOI: 10.3390/ph15020208.

International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function.

Barnes N, Ahern G, Becamel C, Bockaert J, Camilleri M, Chaumont-Dubel S Pharmacol Rev. 2020; 73(1):310-520.

PMID: 33370241 PMC: 7770494. DOI: 10.1124/pr.118.015552.

The relationship between perioperative nausea and vomiting and serum serotonin concentrations in patients undergoing cesarean section under epidural anesthesia.

Lim B, Choi S, Jeong Y, Lim Y, Kim Y, Park K Korean J Anesthesiol. 2015; 67(6):384-90.

PMID: 25558338 PMC: 4280475. DOI: 10.4097/kjae.2014.67.6.384.

Fall in plasma ghrelin concentrations after cisplatin-based chemotherapy in esophageal cancer patients.

Hiura Y, Takiguchi S, Yamamoto K, Kurokawa Y, Yamasaki M, Nakajima K Int J Clin Oncol. 2011; 17(4):316-23.

PMID: 21773688 DOI: 10.1007/s10147-011-0289-0.

Ondansetron: a pharmacoeconomic and quality-of-life evaluation of its antiemetic activity in patients receiving cancer chemotherapy.

Plosker G, Milne R Pharmacoeconomics. 1992; 2(4):285-304.

PMID: 10147044 DOI: 10.2165/00019053-199202040-00005.

References

Feldman J, Plonk J, Cornette J . Serum prostaglandin F-2 alpha concentration in the carcinoid syndrome. Prostaglandins. 1974; 7(6):501-6. DOI: 10.1016/0090-6980(74)90094-x. View

TYCE G, Creagan E . Measurement of free and bound 5-hydroxytryptophan in plasma by liquid chromatography with electrochemical detection. Anal Biochem. 1981; 112(1):143-50. DOI: 10.1016/0003-2697(81)90271-2. View

Miner W, Sanger G . Inhibition of cisplatin-induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism. Br J Pharmacol. 1986; 88(3):497-9. PMC: 1916988. DOI: 10.1111/j.1476-5381.1986.tb10228.x. View

Costall B, Domeney A, Naylor R, Tattersall F . 5-Hydroxytryptamine M-receptor antagonism to prevent cisplatin-induced emesis. Neuropharmacology. 1986; 25(8):959-61. DOI: 10.1016/0028-3908(86)90030-4. View

Leibundgut U, Lancranjan I . First results with ICS 205-930 (5-HT3 receptor antagonist) in prevention of chemotherapy-induced emesis. Lancet. 1987; 1(8543):1198. DOI: 10.1016/s0140-6736(87)92159-3. View

Cunningham D, Hawthorn J, Pople A, Gazet J, Ford H, Challoner T . Prevention of emesis in patients receiving cytotoxic drugs by GR38032F, a selective 5-HT3 receptor antagonist. Lancet. 1987; 1(8548):1461-3. DOI: 10.1016/s0140-6736(87)92208-2. View

Marty M, Pouillart P, Scholl S, Droz J, Azab M, Brion N . Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis. N Engl J Med. 1990; 322(12):816-21. DOI: 10.1056/NEJM199003223221205. View

Ortiz J, Artigas F, Gelpi E . Serotonergic status in human blood. Life Sci. 1988; 43(12):983-90. DOI: 10.1016/0024-3205(88)90543-7. View

Kris M, Gralla R, Clark R, Tyson L . Phase II trials of the serotonin antagonist GR38032F for the control of vomiting caused by cisplatin. J Natl Cancer Inst. 1989; 81(1):42-6. DOI: 10.1093/jnci/81.1.42. View

10.

Higgins G, Kilpatrick G, Bunce K, Jones B, Tyers M . 5-HT3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferret. Br J Pharmacol. 1989; 97(1):247-55. PMC: 1854462. DOI: 10.1111/j.1476-5381.1989.tb11948.x. View

11.

Andrews P, Rapeport W, Sanger G . Neuropharmacology of emesis induced by anti-cancer therapy. Trends Pharmacol Sci. 1988; 9(9):334-41. DOI: 10.1016/0165-6147(88)90106-x. View

12.

Cubeddu L, Hoffmann I, Fuenmayor N, Finn A . Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomiting. N Engl J Med. 1990; 322(12):810-6. DOI: 10.1056/NEJM199003223221204. View

13.

Hawthorn J, Ostler K, Andrews P . The role of the abdominal visceral innervation and 5-hydroxytryptamine M-receptors in vomiting induced by the cytotoxic drugs cyclophosphamide and cis-platin in the ferret. Q J Exp Physiol. 1988; 73(1):7-21. DOI: 10.1113/expphysiol.1988.sp003124. View